192 related articles for article (PubMed ID: 18257271)
1. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
Dai Y; Shen L
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2409-12. PubMed ID: 18257271
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Migu Tablet on bone mineral density, serum levels of osteoprotegerin and its ligand and bone metabolic markers in patients with postmenopausal osteoporosis].
Dai Y; Shen L; Yang YP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):696-9. PubMed ID: 17879531
[TBL] [Abstract][Full Text] [Related]
3. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
Guo LJ; Luo XH; Wu XP; Xie H; Zhou HD; Zhang H; Cao XZ; Liao EY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):734-7. PubMed ID: 15949377
[TBL] [Abstract][Full Text] [Related]
4. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
5. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of MMP-1, MMP-2, and TIMP-1 in Chinese women: age-related changes, and the relationships with bone biochemical markers, bone mineral density.
Guo LJ; Luo XH; Wu XP; Shan PF; Zhang H; Cao XZ; Xie H; Liao EY
Clin Chim Acta; 2006 Sep; 371(1-2):137-42. PubMed ID: 16603142
[TBL] [Abstract][Full Text] [Related]
7. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
Shan PF; Wu XP; Zhang H; Luo XH; Cao XZ; Xie H; Liu SP; Pi YZ; Fang TY; Liu H; Chen ZH; Zhong N; Liao EY
Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
[TBL] [Abstract][Full Text] [Related]
9. [Age-related change of bone biochemical markers and their relationships to mineral density in healthy Chinese men].
Zhao Q; Shen LX; Zhang H; Wu XP; Xie H; Shan PF; Cao XZ; Liao EY; Luo XH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1957-61. PubMed ID: 17064589
[TBL] [Abstract][Full Text] [Related]
10. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
11. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
12. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women.
Dai Y; Shen L
Chin Med J (Engl); 2007 Nov; 120(22):2017-21. PubMed ID: 18067789
[TBL] [Abstract][Full Text] [Related]
13. Association between serum soluble membrane type matrix metalloproteinase-1 (MT1-MMP) levels and bone mineral density, and biochemical markers in postmenopausal women.
Ren XH; Peng XD; Wu XP; Liao EY; Sun ZQ
Clin Chim Acta; 2008 Apr; 390(1-2):44-8. PubMed ID: 18230350
[TBL] [Abstract][Full Text] [Related]
14. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
García-Pérez MA; Moreno-Mercer J; Tarín JJ; Cano A
Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
Choi HJ; Im JA; Kim SH
Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
[TBL] [Abstract][Full Text] [Related]
16. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A
Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319
[TBL] [Abstract][Full Text] [Related]
17. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.
Viapiana O; Gatti D; Dalle Grave R; Todesco T; Rossini M; Braga V; Idolazzi L; Fracassi E; Adami S
Bone; 2007 Apr; 40(4):1073-7. PubMed ID: 17240212
[TBL] [Abstract][Full Text] [Related]
18. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients.
Iba K; Takada J; Yamashita T
J Bone Miner Metab; 2004; 22(6):594-6. PubMed ID: 15490270
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
[TBL] [Abstract][Full Text] [Related]
20. [Age-related changes serum levels of MMP-1 and MMP-2 in women: their relationship with bone biochemical markers and bone mineral density].
Zhang H; Luo XH; Xie H; Wu XP; Shan PF; Cao XZ; Liao EY
Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):306-9. PubMed ID: 16780680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
